120 related articles for article (PubMed ID: 37277019)
1. FBXW10-S6K1 promotes ANXA2 polyubiquitination and KRAS activation to drive hepatocellular carcinoma development in males.
Liu ZY; Lin XT; Zhang YJ; Gu YP; Yu HQ; Fang L; Li CM; Wu D; Zhang LD; Xie CM
Cancer Lett; 2023 Jul; 566():216257. PubMed ID: 37277019
[TBL] [Abstract][Full Text] [Related]
2. Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.
Lin XT; Zhang J; Liu ZY; Wu D; Fang L; Li CM; Yu HQ; Xie CM
Cell Rep; 2023 Jul; 42(7):112812. PubMed ID: 37450367
[TBL] [Abstract][Full Text] [Related]
3. FBXW10 promotes hepatocarcinogenesis in male patients and mice.
Luo YD; Zhang J; Fang L; Zhu YY; You YM; Zhang CC; Zheng P; Zhang LD; Yin LY; Xia F; Bie P; Xie CM
Carcinogenesis; 2020 Jul; 41(5):689-698. PubMed ID: 31400758
[TBL] [Abstract][Full Text] [Related]
4. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS
Xiong HJ; Yu HQ; Zhang J; Fang L; Wu D; Lin XT; Xie CM
Mil Med Res; 2023 Dec; 10(1):68. PubMed ID: 38124228
[TBL] [Abstract][Full Text] [Related]
5. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.
Zhang HJ; Yao DF; Yao M; Huang H; Wang L; Yan MJ; Yan XD; Gu X; Wu W; Lu SL
World J Gastroenterol; 2013 Jun; 19(24):3792-801. PubMed ID: 23840117
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma.
Lou Y; Yu Y; Xu X; Zhou S; Shen H; Fan T; Wu D; Yin J; Li G
J Cell Mol Med; 2019 Mar; 23(3):1873-1884. PubMed ID: 30588744
[TBL] [Abstract][Full Text] [Related]
7. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
[TBL] [Abstract][Full Text] [Related]
8. hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2.
Li J; Yu Z; Zhu Q; Tao C; Xu Q
Cell Transplant; 2020; 29():963689720968748. PubMed ID: 33121269
[TBL] [Abstract][Full Text] [Related]
9. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circ_0021093 regulates miR-432/Annexin A2 pathway to promote hepatocellular carcinoma progression.
Wang Y; Xu W; Zu M; Xu H
Anticancer Drugs; 2021 Jun; 32(5):484-495. PubMed ID: 33675609
[TBL] [Abstract][Full Text] [Related]
11. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells.
Zhang W; Zhao P; Xu XL; Cai L; Song ZS; Cao DY; Tao KS; Zhou WP; Chen ZN; Dou KF
PLoS One; 2013; 8(8):e67268. PubMed ID: 23950866
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
[TBL] [Abstract][Full Text] [Related]
13. Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p.
Ou H; Liu Q; Lin J; He W; Zhang W; Ma J; Wang W
Dig Dis Sci; 2021 Nov; 66(11):3903-3915. PubMed ID: 33398718
[TBL] [Abstract][Full Text] [Related]
14. FBXW10: a male-biased E3 ligase in liver cancer.
Sahay O; Barik GK; Islam S
Trends Cancer; 2023 Nov; 9(11):876-878. PubMed ID: 37775405
[TBL] [Abstract][Full Text] [Related]
15. Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation.
Lin XT; Yu HQ; Fang L; Tan Y; Liu ZY; Wu D; Zhang J; Xiong HJ; Xie CM
Elife; 2021 Nov; 10():. PubMed ID: 34779401
[TBL] [Abstract][Full Text] [Related]
16. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour].
Zhang H; Yao M; Qian Q; Shi Y; Li J; Chen X; Wang S; Yao D
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):620-4. PubMed ID: 25243965
[TBL] [Abstract][Full Text] [Related]
18. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.
Zhang J; Lin XT; Yu HQ; Fang L; Wu D; Luo YD; Zhang YJ; Xie CM
Exp Mol Med; 2023 Oct; 55(10):2162-2176. PubMed ID: 37653031
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer.
Zhang ZY; Sun JH; Liang MJ; Wang XP; Guan J; Zhou ZQ
Int J Biochem Cell Biol; 2023 May; 158():106408. PubMed ID: 36990424
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
